Skip to main content
SpringerLink
Log in

miR-375 Combined with SHOX2 Methylation has Higher Diagnostic Efficacy for Non-Small-Cell Lung Cancer

  • Original Paper
  • Published:
Molecular Biotechnology Aims and scope Submit manuscript

Abstract

Non-small-cell lung cancer (NSCLC) is a high-risk type of lung cancer. This study aims to improve the diagnostic efficacy of NSCLC through the combined detection of miR-375 and short-stature homeobox 2 (SHOX2) methylation. Patients with NSCLC (n = 121) and benign lung disease (BLD) (n = 121) were included. miR-375 and SHOX2 methylation levels were detected. The correlations between miR-375, SHOX2 methylation, and clinical characteristics of NSCLC were analyzed. The diagnostic efficacy of miR-375, SHOX2 methylation, and their combined detection was analyzed. The risk factors of NSCLC were analyzed. The results showed that levels of miR-375 and SHOX2 methylation in NSCLC patients were higher than those in BLD. High expression of miR-375 and positive SHOX2 methylation indicated worse pathological features of NSCLC patients. miR-375 combined with SHOX2 methylation had higher diagnostic efficacy than the single diagnosis. miR-375, SHOX2 methylation, smoking history, neuron-specific enolase (NSE), and CYFRA21-1 levels were risk factors for NSCLC; the risk of NSCLC increased 25.763 times for each unit increase in plasma miR-375 level (OR = 25.763, CI: 1.726–384.529), and the risk of NSCLC increased 4.096 times for each unit increase in SHOX2 methylation (OR = 4.096, CI: 1.195–14.036). miR-375 targeted SHOX2. Overall, miR-375 and SHOX2 methylation and their combined detection were expected to be biomarkers for the diagnosis of NSCLC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Data availability

All the data generated or analyzed during this study are included in this published article.

References

  1. Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 68, 394–424.

    PubMed  Google Scholar 

  2. Liu, X., & Cho, W. C. (2017). Precision medicine in immune checkpoint blockade therapy for non-small cell lung cancer. Clinical and Translational Medicine, 6, 7.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Fu, Y., Liu, L., Zhan, J., Zhan, H., & Qiu, C. (2021). LncRNA GAS5 expression in non-small cell lung cancer tissues and its correlation with Ki67 and EGFR. Am J Transl Res, 13, 4900–4907.

    CAS  PubMed  PubMed Central  Google Scholar 

  4. Xia, Q., Chen, G., Ren, Y., Zheng, T., Shen, C., Li, M., Chen, X., Zhai, H., Li, Z., Xu, J., Gu, A., Jin, M., & Fan, L. (2021). Investigating efficacy of “microbiota modulation of the gut-lung Axis” combined with chemotherapy in patients with advanced NSCLC: Study protocol for a multicenter, prospective, double blind, placebo controlled, randomized trial. BMC Cancer, 21, 721.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Schotten, L. M., Darwiche, K., Seweryn, M., Yildiz, V., Kneuertz, P. J., Eberhardt, W. E. E., Eisenmann, S., Welter, S., Sisson, B. E., Pietrzak, M., Wiesweg, M., Ploenes, T., Hager, T., He, K., Freitag, L., Aigner, C., Taube, C., & Oezkan, F. (2021). DNA methylation of PTGER4 in peripheral blood plasma helps to distinguish between lung cancer, benign pulmonary nodules and chronic obstructive pulmonary disease patients. European Journal of Cancer, 147, 142–150.

    Article  CAS  PubMed  Google Scholar 

  6. Goebel, C., Louden, C. L., McKenna, R., Jr., Onugha, O., Wachtel, A., & Long, T. (2019). Diagnosis of non-small cell lung cancer for early stage asymptomatic patients. Cancer Genomics & Proteomics, 16, 229–244.

    Article  CAS  Google Scholar 

  7. Jia, J., Sun, J., Wang, W., & Yong, H. (2021). Long noncoding RNA MLK7-AS1 promotes non-small-cell lung cancer migration and invasion via the miR-375-3p/YWHAZ Axis. Frontiers in Oncology, 11, 626036.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Han, F., Chen, G., Guo, Y., Li, B., Sun, Y., Qi, X., Tian, H., Zhao, X., & Zhang, H. (2021). MicroRNA-4491 enhances cell proliferation and inhibits cell apoptosis in non-small cell lung cancer via targeting TRIM7. Oncology Letters, 22, 591.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Zhong, S., Golpon, H., Zardo, P., & Borlak, J. (2021). miRNAs in lung cancer. A systematic review identifies predictive and prognostic miRNA candidates for precision medicine in lung cancer. Translational Research, 230, 164–196.

    Article  CAS  PubMed  Google Scholar 

  10. Huang, W., Yan, Y., Liu, Y., Lin, M., Ma, J., Zhang, W., Dai, J., Li, J., Guo, Q., Chen, H., Makabel, B., Liu, H., Su, C., Bi, H., & Zhang, J. (2020). Exosomes with low miR-34c-3p expression promote invasion and migration of non-small cell lung cancer by upregulating integrin alpha2beta1. Signal Transduction and Targeted Therapy, 5, 39.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Abramovic, I., Vrhovec, B., Skara, L., Vrtaric, A., Nikolac, G. N., Kulis, T., Stimac, G., Ljiljak, D., Ruzic, B., Kastelan, Z., Kruslin, B., Bulic-Jakus, F., Ulamec, M., Katusic-Bojanac, A., & Sincic, N. (2021). MiR-182–5p and miR-375–3p have higher performance than PSA in discriminating prostate cancer from benign prostate hyperplasia. Cancers (Basel), 13, 2068.

    Article  CAS  PubMed  Google Scholar 

  12. Chen, L. J., Li, X. Y., Zhao, Y. Q., Liu, W. J., Wu, H. J., Liu, J., Mu, X. Q., & Wu, H. B. (2017). Down-regulated microRNA-375 expression as a predictive biomarker in non-small cell lung cancer brain metastasis and its prognostic significance. Pathology, Research and Practice, 213, 882–888.

    Article  CAS  PubMed  Google Scholar 

  13. Guan, X., Shi, A., Zou, Y., Sun, M., Zhan, Y., Dong, Y., & Fan, Z. (2021). EZH2-mediated microRNA-375 upregulation promotes progression of breast cancer via the inhibition of FOXO1 and the p53 signaling pathway. Frontiers in Genetics, 12, 633756.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Yoda, S., Soejima, K., Hamamoto, J., Yasuda, H., Nakayama, S., Satomi, R., Terai, H., Ikemura, S., Sato, T., Naoki, K., & Betsuyaku, T. (2014). Claudin-1 is a novel target of miR-375 in non-small-cell lung cancer. Lung Cancer, 85, 366–372.

    Article  PubMed  Google Scholar 

  15. Palanca-Ballester, C., Rodriguez-Casanova, A., Torres, S., Calabuig-Farinas, S., Exposito, F., Serrano, D., Redin, E., Valencia, K., Jantus-Lewintre, E., Diaz-Lagares, A., Montuenga, L., Sandoval, J., & Calvo, A. (2021). Cancer epigenetic biomarkers in liquid biopsy for high incidence malignancies. Cancers (Basel), 13, 3016.

    Article  CAS  PubMed  Google Scholar 

  16. Ren, M., Wang, C., Sheng, D., Shi, Y., Jin, M., & Xu, S. (2017). Methylation analysis of SHOX2 and RASSF1A in bronchoalveolar lavage fluid for early lung cancer diagnosis. Annals of Diagnostic Pathology, 27, 57–61.

    Article  PubMed  Google Scholar 

  17. Dietrich, D., Hasinger, O., Liebenberg, V., Field, J. K., Kristiansen, G., & Soltermann, A. (2012). DNA methylation of the homeobox genes PITX2 and SHOX2 predicts outcome in non-small-cell lung cancer patients. Diagnostic Molecular Pathology, 21, 93–104.

    Article  CAS  PubMed  Google Scholar 

  18. Zang, R., Wang, X., Jin, R., Lei, Y., Huang, J., Liu, C., Zheng, S., Zhou, F., Wu, Q., Sun, N., Gao, S., & He, J. (2019). Translational value of IDH1 and DNA methylation biomarkers in diagnosing lung cancers: A novel diagnostic panel of stage and histology-specificity. Journal of Translational Medicine, 17, 430.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Kneip, C., Schmidt, B., Seegebarth, A., Weickmann, S., Fleischhacker, M., Liebenberg, V., Field, J. K., & Dietrich, D. (2011). SHOX2 DNA methylation is a biomarker for the diagnosis of lung cancer in plasma. Journal of Thoracic Oncology, 6, 1632–1638.

    Article  PubMed  Google Scholar 

  20. Yi, J., Jin, L., Chen, J., Feng, B., He, Z., Chen, L., & Song, H. (2017). MiR-375 suppresses invasion and metastasis by direct targeting of SHOX2 in esophageal squamous cell carcinoma. Acta Biochimica et Biophysica Sinica (Shanghai), 49, 159–169.

    Article  CAS  Google Scholar 

  21. Hwang J.K., Page B.J., Flynn D., Passmore L., McCaul E., Brady J., Yang I.A., Marshall H., Windsor M., Bowman R.V., Naidoo R., Guan T., Philpot S., Blake M.E., Fong K.M. (2020). Validation of the Eighth Edition TNM Lung Cancer Staging System. J Thorac Oncol, 15,649–654.

  22. Shi, J., Chen, X., Zhang, L., Fang, X., Liu, Y., Zhu, X., Zhang, H., Fan, L., Gu, J., Zhang, S., She, B., Han, H., & Yi, X. (2020). Performance evaluation of SHOX2 and RASSF1A methylation for the aid in diagnosis of lung cancer based on the analysis of FFPE specimen. Frontiers in Oncology, 10, 565780.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Yuan, M., Huang, L. L., Chen, J. H., Wu, J., & Xu, Q. (2019). The emerging treatment landscape of targeted therapy in non-small-cell lung cancer. Signal Transduction and Targeted Therapy, 4, 61.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Li, M., Shan, W., Hong, B., Zou, J., Li, H., Han, D., Zhang, Y., Li, L., Li, D., & Lin, W. (2020). Circulating miR-92b and miR-375 for monitoring the chemoresistance and prognosis of small cell lung cancer. Science and Reports, 10, 12705.

    Article  CAS  Google Scholar 

  25. Giles, A. E., Teferi, Y., Kidane, B., Bayaraa, B., Tan, L., Buduhan, G., & Srinathan, S. (2021). Lung resection without tissue diagnosis: a pragmatic perspective on the indeterminate pulmonary nodule. Clinical Lung Cancer, 22, e774–e781.

    Article  PubMed  Google Scholar 

  26. Huang, W., Huang, H., Zhang, S., Wang, X., Ouyang, J., Lin, Z., & Chen, P. (2020). A novel diagnosis method based on methylation analysis of SHOX2 and serum biomarker for early stage lung cancer. Cancer Control, 27, 1073274820969703.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Gan, T. Q., Chen, W. J., Qin, H., Huang, S. N., Yang, L. H., Fang, Y. Y., Pan, L. J., Li, Z. Y., & Chen, G. (2017). Clinical value and prospective pathway signaling of MicroRNA-375 in lung adenocarcinoma: a study based on the Cancer Genome Atlas (TCGA), Gene Expression Omnibus (GEO) and bioinformatics analysis. Medical Science Monitor, 23, 2453–2464.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Schneider, K. U., Dietrich, D., Fleischhacker, M., Leschber, G., Merk, J., Schaper, F., Stapert, H. R., Vossenaar, E. R., Weickmann, S., Liebenberg, V., Kneip, C., Seegebarth, A., Erdogan, F., Rappold, G., & Schmidt, B. (2011). Correlation of SHOX2 gene amplification and DNA methylation in lung cancer tumors. BMC Cancer, 11, 102.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Su, Y. Y., Sun, L., Guo, Z. R., Li, J. C., Bai, T. T., Cai, X. X., Li, W. H., & Zhu, Y. F. (2019). Upregulated expression of serum exosomal miR-375 and miR-1307 enhance the diagnostic power of CA125 for ovarian cancer. J Ovarian Res, 12, 6.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Su, Y., Fang, H., & Jiang, F. (2016). Integrating DNA methylation and microRNA biomarkers in sputum for lung cancer detection. Clinical Epigenetics, 8, 109.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Jeon, J., Holford, T. R., Levy, D. T., Feuer, E. J., Cao, P., Tam, J., Clarke, L., Clarke, J., Kong, C. Y., & Meza, R. (2018). Smoking and lung cancer mortality in the United States From 2015 to 2065: A comparative modeling approach. Annals of Internal Medicine, 169, 684–693.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Hong, S., Noh, H., Teng, Y., Shao, J., Rehmani, H., Ding, H. F., Dong, Z., Su, S. B., Shi, H., Kim, J., & Huang, S. (2014). SHOX2 is a direct miR-375 target and a novel epithelial-to-mesenchymal transition inducer in breast cancer cells. Neoplasia, 16(279–90), e1-5.

    Google Scholar 

  33. Li, N., Zeng, Y., Tai, M., Lin, B., Zhu, D., Luo, Y., Ren, X., Zhu, X., Li, L., Wu, H., & Huang, J. (2021). Analysis of the prognostic value and gene expression mechanism of SHOX2 in lung adenocarcinoma. Frontiers in Molecular Biosciences, 8, 688274.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

Not applicable.

Funding

This study was supported by Hunan Provincial Commission of Health Scientific Research Project (No.20201946). The funding body didn’t participate in the design of the study and collection, analysis, and interpretation of the data and in writing the manuscript.

Author information

Authors and Affiliations

  1. Department of Pulmonary and Critical Care Medicine, The Second Affiliated Hospital, Hengyang Medical School, University of South China, No. 30, Jiefang Road, Shigu District, Hengyang, 421000, Hunan, China

    Saili Zeng & Yuling Huang

  2. Department of Gynecology, Hunan Province Maternal and Child Health Care Hospital, 53 Xiangchun Road, Kaifu District, Changsha, 410008, Hunan, China

    Chunli Lin

Authors
  1. Saili Zeng
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Chunli Lin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yuling Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Saili Zeng or Chunli Lin.

Ethics declarations

Competing interest

The authors declared that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zeng, S., Lin, C. & Huang, Y. miR-375 Combined with SHOX2 Methylation has Higher Diagnostic Efficacy for Non-Small-Cell Lung Cancer. Mol Biotechnol 65, 1187–1197 (2023). https://doi.org/10.1007/s12033-022-00604-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12033-022-00604-y

Keywords

Search

Navigation